Best practice for self-monitoring the effect of medicines prescribed for treating chronic disease, such as diabetes, hypertension, and respiratory disease

Overview

Patient self-monitoring (blood glucose monitoring in diabetes, peak flow/symptom diaries in respiratory disease, and similar tools in other chronic conditions) empowers patients to track treatment effect between clinical reviews, supporting earlier detection of deterioration and more informed shared decision-making about treatment adjustment
Relevant across chronic disease management broadly, with self-monitoring tool selection and target-setting individualised to the specific condition, patient capability, and treatment goals

Self-monitoring provides much higher-frequency data than periodic clinical review alone can capture, allowing detection of trends and patterns (e.g. glucose variability, symptom triggers) that a single clinic-based measurement would miss entirely - this temporal density is the core value proposition distinguishing self-monitoring from standard intermittent clinical assessment

Self-monitoring tool selection should match the specific condition and treatment being monitored (e.g. home blood glucose monitoring most valuable for insulin-treated diabetes where real-time dose adjustment decisions depend on it, versus less frequently needed for diet-controlled type 2 diabetes)
Structured patient education on correct technique, target ranges, and when to seek clinical review based on results is essential for self-monitoring to translate into improved outcomes rather than generating anxiety or unused data

Self-monitored data should directly inform shared treatment adjustment decisions (e.g. insulin dose titration based on home glucose readings) rather than being collected without a clear action plan attached to specific results
Over-monitoring (more frequent than clinically useful) can create burden and anxiety without proportionate benefit, so monitoring frequency should be matched to genuine clinical need

Home blood glucose monitoring and insulin dose titration, continuous glucose monitoring technology, peak flow diaries in asthma self-management plans, patient-reported outcome tracking in chronic disease

Self-monitoring is most valuable when tied to a clear, pre-agreed action plan (specific result thresholds triggering specific patient actions or clinical contact) rather than data collection alone - monitoring without an attached action plan risks generating patient burden and anxiety without translating into improved clinical outcomes

5 more sections, plus exam facts

Premium unlocks every note across every specialty, and the full exam fact library behind it.